MINARI, Roberta

MINARI, Roberta  

Dipartimento di Medicina Clinica e Sperimentale (attivo dal 20/07/2012 al 31/12/2016)  

Mostra records
Risultati 1 - 20 di 42 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autore(i) File
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 1-gen-2022 Mazzaschi, G.; Moron Dalla Tor, L.; Balbi, M.; Milanese, G.; Tognazzi, D.; Lorusso, B.; Trentini, F.; Di Rienzo, G.; Verzè, M.; Pluchino, M.; Minari, R.; Leo, L.; Gnetti, L.; Bordi, P.; Leonetti, A.; Ampollini, L.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy 1-gen-2021 Mazzaschi, G.; Scandino, R.; Milanese, G.; Pavone, C.; Maurizio, B.; Silva, M.; Ledda, R.; Minari, R.; Trentini, F.; Buti, S.; Bordi, P.; Leonetti, A.; Quaini, F.; Sverzellati, N.; Romanel, A.; Tiseo, M.
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 1-gen-2021 Mazzaschi, G.; Milanese, G.; Moron Dalla Tor, L.; Leo, L.; Balbi, M.; Trentini, F.; Manini, M.; Pavone, C.; Silva, M.; Ledda, R. E.; Minari, R.; Bordi, P.; Buti, S.; Leonetti, A.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 1-gen-2023 Mazzaschi, G.; Bocchialini, G.; Lorusso, B.; Pluchino, M.; Trentini, F.; Di Rienzo, G.; Cattadori, S.; Tor, L. Moron Dalla; Verzè, M.; Minari, R.; Bordi, P.; Leonetti, A.; D’Agnelli, S.; Milanese, G.; Leo, L.; Gnetti, L.; Roti, G.; Ampollini, L.; Quaini, F.; Sverzellati, N.; Tiseo, M.
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 1-gen-2020 Mazzaschi, G.; Minari, R.; Ferri, V.; Bordi, P.; Gnetti, L.; Bersanelli, M.; Cavazzoni, A.; Buti, S.; Leonetti, A.; Zecca, A.; Cosenza, A.; Ferri, L.; Rapacchi, E.; Mori, C.; Petronini, P. G.; Missale, G.; Quaini, F.; Tiseo, M.
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 1-gen-2023 Mazzaschi, G.; Cardinale, E.; Pluchino, M.; Monica, G.; Lorusso, B.; D'Agnelli, S.; Trentini, F.; Tamarozzi, P.; Dalla Tor, L. Moron; Verzè, M.; Minari, R.; Bordi, P.; Perrone, F.; Leonetti, A.; Gnetti, L.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
7P STK11 and Galectin-3 tissue expression entails a prognostic signature in immunotherapy treated NSCLC patients 1-gen-2021 Mazzaschi, G.; Minari, R.; Gnetti, L.; Campanini, N.; Zielli, T.; Baucina, M.; Perrone, F.; Leonetti, A.; Quaini, F.; Tiseo, M.
A novel mutation in the nr0b1 gene in a family with monozygotic twin sisters and congenital adrenal hypoplasia affected children. 1-gen-2015 Minari, Roberta; Vottero, Alessandra; F., Tassi; Viani, Isabella; T. M., Neri; Street, Maria Elisabeth; Ghizzoni, Lucia; Bernasconi, Sergio; D., Martorana
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine 1-gen-2021 Ferlenghi, F; Scalvini, L; Vacondio, F; Castelli, R; Bozza, N; Marseglia, G; Rivara, S; Lodola, A; La Monica, S; Minari, R; Petronini, Pg; Alfieri, R; Tiseo, M; Mor, M.
Circulating TGF-Beta and PD-L1 in Pancreatic Cancer 1-gen-2022 Garajova, Ingrid; Cavazzoni, Andrea; Verze, Michela; Minari, Roberta; Pedrazzi, Giuseppe; Balsano, Rita; Digiacomo, Graziana; Leonardi, Francesco
Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: review of the literature and future perspectives 1-gen-2020 Rebuzzi, Sara Elena; Alfieri, Roberta; La Monica, Silvia; Minari, Roberta; Petronini, Pier Giorgio; Tiseo, Marcello
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 1-gen-2018 Minari, Roberta; Bordi, Paola; La Monica, Silvia; Squadrilli, Anna; Leonetti, Alessandro; Bottarelli, Lorena; Azzoni, Cinzia; Lagrasta, Costanza Anna Maria; Gnetti, Letizia; Campanini, Nicoletta; Petronini, Pier Giorgio; Alfieri, Roberta; Tiseo, Marcello
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study 1-gen-2020 Minari, R.; Mazzaschi, G.; Bordi, P.; Gnetti, L.; Alberti, G.; Altimari, A.; Gruppioni, E.; Sperandi, F.; Parisi, C.; Guaitoli, G.; Bettelli, S.; Longo, L.; Bertolini, F.; Pagano, M.; Bonelli, C.; Tagliavini, E.; Nicoli, D.; Ubiali, A.; Zangrandi, A.; Trubini, S.; Proietto, M.; Fiorentino, M.; Tiseo, M.
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 1-gen-2022 Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib 1-gen-2021 LA Monica, S.; Fumarola, C.; Cretella, D.; Bonelli, M.; Minari, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Volta, F.; Mancini, M.; Petronini, P. G.; Tiseo, M.; Alfieri, R.
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 1-gen-2020 Minari, R.; Gnetti, L.; Lagrasta, C. A.; Squadrilli, A.; Bordi, P.; Azzoni, C.; Bottarelli, L.; Cosenza, A.; Ferri, L.; Caruso, G.; Silini, E. M.; Tiseo, M.
Evidence fo Epigenetic Abnormalities of the Androgen Receptor Gene in Foreskin from Children with Hypospadias 1-gen-2011 Vottero, Alessandra; Minari, Roberta; Viani, Isabella; F., Tassi; Bonatti, Francesco; Neri, Tauro Maria; Bertolini, Lorenzo; Bernasconi, Sergio; Ghizzoni, Lucia
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. 1-gen-2019 Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg.
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 1-gen-2019 Bordi, P.; Del Re, M.; Minari, R.; Rofi, E.; Buti, S.; Restante, G.; Squadrilli, A.; Crucitta, S.; Casartelli, C.; Gnetti, L.; Azzoni, C.; Bottarelli, L.; Petrini, I.; Cosenza, A.; Ferri, L.; Rapacchi, E.; Danesi, R.; Tiseo, M.
Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC 1-gen-2019 Mazzaschi, G.; Minari, R.; Ferri, V.; Gnetti, L.; Bersanelli, M.; Cavazzoni, A.; Bordi, P.; Squadrilli, A.; Buti, S.; Cosenza, A.; Ferri, L.; Rapacchi, E.; Petronini, P. G.; Missale, G.; Quaini, F.; Tiseo, M.